Download this article's Factoid in PDF (& PPT for Gold Subscribers)
 

For revascularization of restenosis in a drug-eluting stent (DES), a paclitaxel-coated balloon is more effective in reducing late loss and early clinical events, particularly target lesion revascularization (TLR), compared with conventional balloon angioplasty.

The findings, which were first presented in November 2011 at the annual Transcatheter Cardiovascular Therapeutics scientific symposium in San Francisco, CA, were published online February 29, 2012, ahead of print in the Journal of the American College of Cardiology.

For the multicenter PEPCAD-DES trial, investigators led by Harald Rittger, MD, of Universitätsklinikum Erlangen ....

You must be logged in to access this content.

To continue, please enter your username and password above.

If you do not yet have a free TCTMD account, please:

For questions regarding the registration process, please refer to our FAQ documentation or contact customer service.